These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 33774764)

  • 1. Superior outcomes with Argatroban for heparin-induced thrombocytopenia: a Bayesian network meta-analysis.
    Colarossi G; Maffulli N; Trivellas A; Schnöring H; Hatam N; Tingart M; Migliorini F
    Int J Clin Pharm; 2021 Aug; 43(4):825-838. PubMed ID: 33774764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparisons of argatroban to lepirudin and bivalirudin in the treatment of heparin-induced thrombocytopenia: a systematic review and meta-analysis.
    Sun Z; Lan X; Li S; Zhao H; Tang Z; Xi Y
    Int J Hematol; 2017 Oct; 106(4):476-483. PubMed ID: 28600720
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of bivalirudin to lepirudin and argatroban in patients with heparin-induced thrombocytopenia.
    Bain J; Meyer A
    Am J Health Syst Pharm; 2015 Sep; 72(17 Suppl 2):S104-9. PubMed ID: 26272889
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of argatroban and bivalirudine in patients with suspected heparin-induced thrombocytopenia.
    Vo QA; Lin JK; Tong LM
    Ann Pharmacother; 2015 Feb; 49(2):178-84. PubMed ID: 25515865
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of treatment with direct thrombin inhibitors in patients with heparin-induced thrombocytopenia.
    Dang CH; Durkalski VL; Nappi JM
    Pharmacotherapy; 2006 Apr; 26(4):461-8. PubMed ID: 16553503
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized, open-label pilot study comparing desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis: PREVENT-HIT Study.
    Boyce SW; Bandyk DF; Bartholomew JR; Frame JN; Rice L
    Am J Ther; 2011 Jan; 18(1):14-22. PubMed ID: 21079512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of Fondaparinux Off-Label or Approved Anticoagulants for Management of Heparin-Induced Thrombocytopenia.
    Schindewolf M; Steindl J; Beyer-Westendorf J; Schellong S; Dohmen PM; Brachmann J; Madlener K; Pötzsch B; Klamroth R; Hankowitz J; Banik N; Eberle S; Müller MM; Kropff S; Lindhoff-Last E
    J Am Coll Cardiol; 2017 Nov; 70(21):2636-2648. PubMed ID: 29169470
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationale and design of the PREVENT-HIT study: a randomized, open-label pilot study to compare desirudin and argatroban in patients with suspected heparin-induced thrombocytopenia with or without thrombosis.
    Frame JN; Rice L; Bartholomew JR; Whelton A
    Clin Ther; 2010 Apr; 32(4):626-36. PubMed ID: 20435232
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of patients with a history of heparin-induced thrombocytopenia and anti-lepirudin antibodies with argatroban.
    Harenberg J; Jörg I; Fenyvesi T; Piazolo L
    J Thromb Thrombolysis; 2005 Feb; 19(1):65-9. PubMed ID: 15976970
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A comparison of direct thrombin inhibitors in the treatment of Heparin-Induced Thrombocytopenia: a single institution experience.
    Curzio KM; Cheng-Lai A; Kheyfets V; Sinnet M; Billett HH
    J Thromb Thrombolysis; 2009 Aug; 28(2):117-23. PubMed ID: 18827975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Management of heparin-induced thrombocytopenia: a critical comparison of lepirudin and argatroban.
    Warkentin TE
    Thromb Res; 2003 May; 110(2-3):73-82. PubMed ID: 12893020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of diagnostic tests and argatroban or lepirudin therapy in patients with suspected heparin-induced thrombocytopenia.
    Kiser TH; Jung R; MacLaren R; Fish DN
    Pharmacotherapy; 2005 Dec; 25(12):1736-45. PubMed ID: 16305293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying patient- and treatment-related factors related to amputation risk in cases of heparin-induced thrombocytopenia treated with argatroban.
    Haas S; Lewis B
    Int Angiol; 2011 Dec; 30(6):541-6. PubMed ID: 22233615
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Argatroban therapy for heparin-induced thrombocytopenia in ICU patients with multiple organ dysfunction syndrome: a retrospective study.
    Saugel B; Phillip V; Moessmer G; Schmid RM; Huber W
    Crit Care; 2010; 14(3):R90. PubMed ID: 20487559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Argatroban, a new antithrombotic treatment for heparin-induced thrombocytopenia application in cardiac surgery and in intensive care].
    Rozec B; Boissier E; Godier A; Cinotti R; Stephan F; Blanloeil Y
    Ann Fr Anesth Reanim; 2014; 33(9-10):514-23. PubMed ID: 25148720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing argatroban in heparin-induced thrombocytopenia: A retrospective analysis of 729 treatment days in 32 patients with confirmed heparin-induced thrombocytopenia.
    Marchetti M; Barelli S; Gleich T; Gomez FJ; Goodyer M; Grandoni F; Alberio L
    Br J Haematol; 2022 Jun; 197(6):766-790. PubMed ID: 35358358
    [No Abstract]   [Full Text] [Related]  

  • 17. How we manage patients with heparin induced thrombocytopenia.
    Scully M; Gates C; Neave L
    Br J Haematol; 2016 Jul; 174(1):9-15. PubMed ID: 27097741
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Argatroban versus Lepirudin in critically ill patients (ALicia): a randomized controlled trial.
    Treschan TA; Schaefer MS; Geib J; Bahlmann A; Brezina T; Werner P; Golla E; Greinacher A; Pannen B; Kindgen-Milles D; Kienbaum P; Beiderlinden M
    Crit Care; 2014 Oct; 18(5):588. PubMed ID: 25344113
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dabigatran Use after Argatroban for Heparin-induced Thrombocytopenia with Thrombosis: A Case Series and Literature Review.
    Wang Y; Zhang K; Yin L; Fu G; Liu Z
    Ann Vasc Surg; 2022 Mar; 80():392.e1-392.e7. PubMed ID: 34656708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Argatroban use in heparin-induced thrombocytopenia.
    Boggio LN; Oza VM
    Expert Opin Pharmacother; 2008 Aug; 9(11):1963-7. PubMed ID: 18627333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.